Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Study of canerpaturev (TBI-1401/HF10) Plus Chemotherapy in Unresectable Pancreatic Cancer
jRCT1080223615Phase 1Completed
- Sponsor
- Takara Bio Inc.
- Start
- Aug 2017
- Modality
- Oncolytic Viruses → Oncolytic Therapeutics
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of canerpaturev in pancreatic cancer (PC), sponsored by Takara Bio Inc. Started Aug 2017; status: completed.
02
Drugs
canerpaturev
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on jRCT1080223615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223615.